See the Complete Picture.
Get Started
SubscribeLogin
Israel-Hamas Conflict
Pope Leo XIV
Pope Francis
Mother's Day
World War II
Vatican
Catholic Church
Artificial Intelligence
Conclave
Military
Social Media
Baseball
Education
Published • loading... • Updated

Auron Presents Preclinical Data Highlighting the Activity of AUTX-703 in Prostate Cancer at ...

Summary by Hastings Tribune
NEWTON, Mass., April 28, 2025 (GLOBE NEWSWIRE) -- Auron Therapeutics, a clinical-stage biotechnology company targeting cell-state plasticity to improve patient outcomes in oncology and inflammatory disease, today announced preclinical data in prostate cancer at the American Association for Cancer Research…

1 Articles

All
Left
Center
1
Right
Hastings TribuneHastings Tribune
Center

Auron Presents Preclinical Data Highlighting the Activity of AUTX-703 in Prostate Cancer at ...

NEWTON, Mass., April 28, 2025 (GLOBE NEWSWIRE) -- Auron Therapeutics, a clinical-stage biotechnology company targeting cell-state plasticity to improve patient outcomes in oncology and inflammatory disease, today announced preclinical data in prostate cancer at the American Association for Cancer Research…

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Hastings Tribune broke the news in on Monday, April 28, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Newton, Massachusetts

Newton, Massachusetts

News
For You
SearchBlindspotLocal